Published in Environ Health Perspect on May 01, 2004
Triclocarban enhances testosterone action: a new type of endocrine disruptor? Endocrinology (2007) 1.63
Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS One (2008) 1.13
Xenoandrogenic activity in serum differs across European and Inuit populations. Environ Health Perspect (2007) 0.86
Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides. Environ Health Perspect (2012) 0.79
Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis. Toxicol Sci (2014) 0.77
Salbutamol exhibits androgenic activity in vitro. Br J Sports Med (2007) 0.76
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature (1995) 6.33
The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect (1995) 5.37
Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect (1997) 4.62
p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect (1991) 4.52
A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (1995) 3.47
Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol (1994) 2.22
Discovery of nonsteroidal androgens. Biochem Biophys Res Commun (1998) 2.21
Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect (1999) 2.03
Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol (1994) 1.81
In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect (2001) 1.65
Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect (2000) 1.49
Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol (1994) 1.48
Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem (1995) 1.45
A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol Sci (2002) 1.35
Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ Health Perspect (1996) 1.33
Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol (2002) 1.16
Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology (1997) 1.15
The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology (2000) 1.08
The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol Sci (2003) 1.08
Feminization of male carp. Nature (1996) 1.06
Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals. Toxicol Appl Pharmacol (1999) 1.03
The binding properties of pyrethroids to human skin fibroblast androgen receptors and to sex hormone binding globulin. J Steroid Biochem (1990) 1.02
Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect (1998) 0.98
Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. Environ Health Perspect (2001) 0.98
Antiandrogenic effects in vitro and in vivo of the fungicide prochloraz. Toxicol Sci (2002) 0.96
UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol Sci (2003) 0.93
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol Cell Endocrinol (2000) 0.91
Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids. J Steroid Biochem (1987) 0.89
Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. Toxicol Appl Pharmacol (1993) 0.89
Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells. Endocrinology (1997) 0.88
Regulation of human estrogen receptor by phytoestrogens in yeast and human cells. J Steroid Biochem Mol Biol (1998) 0.86
Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Chemosphere (1999) 0.81
Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J Steroid Biochem Mol Biol (1994) 0.81
Adrenal steroids in human prostatic cancer cell lines. Arch Androl (2001) 0.80
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (2007) 4.04
Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev (2008) 4.03
The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci (2004) 3.83
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27
Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology (2006) 2.63
Childhood obesity. J Clin Endocrinol Metab (2004) 2.29
Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect (2007) 2.29
Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol (2006) 2.22
Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology (2005) 2.14
Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab (2002) 2.13
Apparent male gender identity in a patient with complete androgen insensitivity syndrome. Arch Sex Behav (2009) 2.01
Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect (2007) 1.95
Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2006) 1.92
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2006) 1.90
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
Bisphenol A: Perinatal exposure and body weight. Mol Cell Endocrinol (2009) 1.82
Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod (2005) 1.79
Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab (2007) 1.71
Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol (2002) 1.66
Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect (2003) 1.62
Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study. J Clin Endocrinol Metab (2004) 1.61
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril (2008) 1.60
Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol (2008) 1.53
Theories of carcinogenesis: an emerging perspective. Semin Cancer Biol (2008) 1.49
Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol (2005) 1.48
A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods (2008) 1.45
Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev (2002) 1.43
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors. Environ Health (2013) 1.42
Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect (2010) 1.41
Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reprod Toxicol (2010) 1.40
Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J Clin Endocrinol Metab (2013) 1.39
Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry (2002) 1.34
Endocrine disruptors: from Wingspread to environmental developmental biology. J Steroid Biochem Mol Biol (2002) 1.33
Activating mutations of Gsalpha in kidney cancer. J Urol (2006) 1.31
Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology (2006) 1.29
Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect (2007) 1.28
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod (2007) 1.27
The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization? J Steroid Biochem Mol Biol (2006) 1.23
Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab (2010) 1.21
Bisphenol A alters the development of the rhesus monkey mammary gland. Proc Natl Acad Sci U S A (2012) 1.21
Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol Cell Endocrinol (2002) 1.16
Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci U S A (2006) 1.16
The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures. BMC Cancer (2010) 1.16
Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer (2009) 1.15
Endocrine-disrupting effects of cattle feedlot effluent on an aquatic sentinel species, the fathead minnow. Environ Health Perspect (2004) 1.14
Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environ Health Perspect (2007) 1.13
Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab (2006) 1.13
Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ Health Perspect (2013) 1.13
Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab (2008) 1.12
Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology (2008) 1.11
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health (2005) 1.11
Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland. PLoS One (2013) 1.11
Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol (2008) 1.08
The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique. J Biosci (2013) 1.08
The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol Sci (2003) 1.08
The death of the cancer cell. Cancer Res (2011) 1.07
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol (2013) 1.07
Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology (2006) 1.07
Hypospadias: etiology and current research. Urol Clin North Am (2010) 1.06
Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol (2006) 1.06
Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl (2008) 1.06
The role of collagen reorganization on mammary epithelial morphogenesis in a 3D culture model. Biomaterials (2010) 1.05
Are structural analogues to bisphenol a safe alternatives? Toxicol Sci (2014) 1.05
Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation. Mol Cell Endocrinol (2012) 1.04
Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril (2007) 1.02
The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. Horm Res Paediatr (2010) 1.01
Steroidogenesis in fetal male rats is reduced by DEHP and DINP, but endocrine effects of DEHP are not modulated by DEHA in fetal, prepubertal and adult male rats. Reprod Toxicol (2004) 0.99
Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci (2010) 0.99
How subchronic and chronic health effects can be neglected for GMOs, pesticides or chemicals. Int J Biol Sci (2009) 0.99
Environmental exposure to lead, but not other neurotoxic metals, relates to core elements of ADHD in Romanian children: performance and questionnaire data. Environ Res (2010) 0.97
Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration. Reprod Biol Endocrinol (2010) 0.97
Diisobutyl phthalate has comparable anti-androgenic effects to di-n-butyl phthalate in fetal rat testis. Toxicol Lett (2006) 0.97
Effects of low doses of bisphenol A on the metabolome of perinatally exposed CD-1 mice. Environ Health Perspect (2013) 0.96
Do parabens have the ability to interfere with steroidogenesis? Toxicol Sci (2008) 0.96
Synergistic disruption of external male sex organ development by a mixture of four antiandrogens. Environ Health Perspect (2009) 0.95
Mutations of CXorf6 are associated with a range of severities of hypospadias. Eur J Endocrinol (2008) 0.95
Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril (2011) 0.95
The effect of stromal components on the modulation of the phenotype of human bronchial epithelial cells in 3D culture. Biomaterials (2011) 0.95
Effects of physical activity on bone remodeling. Metabolism (2010) 0.94
Low-dose perinatal exposure to di(2-ethylhexyl) phthalate induces anti-androgenic effects in male rats. Reprod Toxicol (2010) 0.93
The combined antiandrogenic effects of five commonly used pesticides. Toxicol Appl Pharmacol (2004) 0.93
Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study. Fertil Steril (2011) 0.93
UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol Sci (2003) 0.93
Effect of physical activity on calcium homeostasis and calciotropic hormones: a review. Calcif Tissue Int (2009) 0.93
Clinical review: The emerging cell biology of thyroid stem cells. J Clin Endocrinol Metab (2011) 0.92
Biological effects of fruit and vegetables. Proc Nutr Soc (2006) 0.92
Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. Toxicol Appl Pharmacol (2006) 0.92
Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol (2010) 0.92
Estrogenic activity and estrogen receptor beta binding of the UV filter 3-benzylidene camphor. Comparison with 4-methylbenzylidene camphor. Toxicology (2004) 0.91
Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study. Hum Reprod (2011) 0.91
Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations. Fertil Steril (2009) 0.90
Sexually dimorphic gene regulation in brain as a target for endocrine disrupters: developmental exposure of rats to 4-methylbenzylidene camphor. Toxicol Appl Pharmacol (2006) 0.90
Dysgenesis and histological changes of genitals and perturbations of gene expression in male rats after in utero exposure to antiandrogen mixtures. Toxicol Sci (2007) 0.89
Endocrine disorders in adolescent and young female athletes: impact on growth, menstrual cycles, and bone mass acquisition. J Clin Endocrinol Metab (2014) 0.89
Appendicular skeletal muscle mass is the strongest independent factor associated with femoral neck bone mineral density in adult and older men. Exp Gerontol (2010) 0.88
Effects of currently used pesticides in the AhR-CALUX assay: comparison between the human TV101L and the rat H4IIE cell line. Toxicology (2003) 0.88